Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$103.94 - $118.98 $526,871 - $603,109
5,069 Added 234.68%
7,229 $771,000
Q1 2024

May 14, 2024

BUY
$115.19 - $132.77 $248,810 - $286,783
2,160 New
2,160 $260,000
Q4 2022

Feb 10, 2023

BUY
$129.72 - $159.85 $180,181 - $222,031
1,389 New
1,389 $221,000
Q4 2021

Feb 11, 2022

SELL
$119.87 - $145.67 $1.04 Million - $1.26 Million
-8,649 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$128.64 - $184.79 $1.11 Million - $1.6 Million
8,649 New
8,649 $1.13 Million
Q1 2020

May 08, 2020

SELL
$87.74 - $152.74 $1.16 Million - $2.02 Million
-13,257 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$117.65 - $153.73 $1.56 Million - $2.04 Million
13,257 New
13,257 $1.98 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.